Search by category - Any -Regulated informationInside informationNon-regulated information Search by year - Any -202620252024202320222021202020192018201720162015 7 April 2020 Invitation to the Annual and Extraordinary Shareholders’ Meetings Regulated information 2 April 2020 Biocartis Announces Publication of 2019 Annual Report Regulated information 26 March 2020 Biocartis Announces Co-commercialization of the SeptiCyte® RAPID Test on Idylla™ (CE IVD) and Provides Update on COVID 19 Impact Regulated information 5 March 2020 Biocartis announces 2019 results and 2020 outlook Regulated information 5 March 2020 Biocartis Announces New Immuno-Oncology Project with Bristol-Myers Squibb Aimed at Registration of Idylla™ MSI test in China Non-regulated information 5 March 2020 Biocartis Creates New Share Option Plan & Cancels Outstanding Pool under 2018 Share Option Plan Regulated information 27 February 2020 Biocartis to Host Webcast for Announcement 2019 Financial Results on 5 March 2020 Regulated information 27 January 2020 Biocartis announces resignation CFO Inside information Regulated information 22 January 2020 Biocartis Enters into Master Collaboration Agreement with AstraZeneca and Initiates EGFR Liquid Biopsy Study Non-regulated information 9 January 2020 Biocartis Meets 2019 Key Business Objectives Regulated information Pagination First page « First Previous page ‹‹ … Page 12 Page 13 Page 14 Page 15 Current page 16 Page 17 Page 18 Page 19 Page 20 … Next page ›› Last page Last »